Leading pancreatic cancer scientist fabricated data to defraud charities of hundreds of thousands to fund criminal research

Scientific research
Source: NaturalNews.com
Isabelle Z.
August 17, 2016

Professor Thorsten Hagemann was considered one of the world’s leading pancreatic cancer specialists. He studied medicine in Germany, and earned an MD/PhD with a thesis in oncology in 1999. His resume is filled with impressive experience over the 15 years that followed, including being a Professor for Pancreatic Cancer Medicine at Queen Mary’s University London, as well as St. Bartholomew’s Hospital in the UK. Last fall, he was appointed Medical Director of the London biopharmaceutical firm Immodulon Therapeutics.

However, it turns out that much of his success has been based on fraud. The doctor has now been banned from practicing medicine, after being caught fabricating data in order to convince charities to fund his research.

A number of transgressions have been uncovered which took place throughout his career. He lied about the results of cancer trials, and fudged the numbers to apply for funds from Cancer Research and the Pancreatic Cancer Research Fund. He managed to gain £180,000 from the latter for a project called “Defining the role of regulatory B cells in pancreatic cancer.”

He also inflated figures in an article that was published by the Nature scientific journal. Another paper he submitted to Nature Medicine also contained false data, but was ultimately rejected. The fraudulent data was also used in a presentation he made to Cancer Research Technology.

Adding insult to injury, he lied to his colleagues who worked on the trials with him, even going so far as to edit emails to cover his tracks when they voiced suspicions.

Medical license revoked

A panel has now declared him unfit to practice medicine, and he was been removed from the medical register for “gross and clear fabrication of research data.” He was found guilty of 24 different instances of dishonest and misleading conduct between the years 2012 and 2014. He did not attend his hearing in the UK, and is believed to have left the country.

Most scientific journals publish misleading or false studies

While this is very alarming, and the potential danger that misleading studies can cause the public is hard to quantify, it’s not an isolated incident by any means. In fact, the Editor-in-Chief of one of the world’s premier medical journals, The Lancet, Dr. Richard Horton, has gone on the record as stating that as much as half of all scientific literature published is unreliable at best, and completely false at worst.

He wrote:

The case against science is straightforward: much of the scientific literature, perhaps half, may simply be untrue. Afflicted by studies with small sample sizes, tiny effects, invalid exploratory analyses, and flagrant conflicts of interest, together with an obsession for pursuing fashionable trends of dubious importance, science has taken a turn towards darkness.

The former Editor-in-Chief of the New England Journal of Medicine, Dr. Marcia Angell, echoed his sentiments, saying that clinical trials are designed in a way that makes them yield favorable results for their sponsors. She derided the influence that the pharmaceutical industry has on scientific research.

Unfortunately, the only research that can be trusted these days is studies in publications that are free from corporate fraud, like the Natural Science Journal. Very few mainstream science journals fall into this category, as the influence of biotech and pharmaceutical interests is rampant. This type of fraud gives honest scientists a bad name, so it’s surprising that more of them are not speaking out against this huge problem, which has ramifications for all of human life.

Read More At: NaturalNews.com

Sources include:

Standard.co.uk

BMJ.com

Immodulon.com[PDF]

NaturalNews.com

Science.NaturalNews.com

Frankincense Oil Kills Cancer Cells While Boosting The Immune System, Studies Show

Frankincense
Source: NaturalNews.com
David Gutierrez
July 27, 2016

Frankincense is a powerful medicinal oil that can not only boost the immune system but also kill cancer cells, a number of studies have shown.

One of the most significant recent studies was conducted by researchers from the University of Leicester, England, in 2013. The researchers found that the naturally occurring frankincense compound acetyl-11-keto-beta-boswellic acid (AKBA) targeted and destroyed ovarian cancer cells. The findings were particularly significant because they showed that AKBA had this effect even in late-stage ovarian cancer patients, not just in laboratory trials performed on isolated cells.

“Frankincense is taken by many people with no known side effects,” lead researcher Kamla Al-Salmani said. This finding has enormous potential to be taken to a clinical trial in the future and developed into an additional treatment for ovarian cancer.”

Kills cancer and reduces radiation side effects

The Leicester findings build on a large and still growing body of evidence that frankincense and its compounds have powerful immune-boosting and cancer-fighting benefits.

A study published in BMC Complementary and Alternative Medicine in 2009, for example, found that the herbal form of frankincense triggered death in bladder cancer cells by activating several different cellular pathways. Another study, conducted by researchers from Nihon University in Tokyo and published in Biological and Pharmaceutical Bulletin, showed that several chemical components of frankincense were able to kill three separate human neuroblastoma cell lines. The same study also found that frankincense inhibited the growth of Epstein-Barr virus.

Neuroblastoma is a type of cancer that forms in nerve cells and primarily affects young children. Other studies have shown that frankincense and its components can kill cancers of the brain, breast, colon, pancreas, prostate and stomach.

Frankincense may also help mitigate the often-debilitating side effects of cancer treatment. One study, published in the journal Cancer in 2011, was performed on brain cancer patients experiencing cerebral edema (swelling) as a side effect of radiation therapy. The researchers found that 60 percent of participants given frankincense experienced a 75 percent reduction in cerebral swelling, a potent enough result for the authors to recommend frankincense as a potential alternative to steroids, the current favored treatment. Side effects of steroids can include headaches, blurred vision and migraines.

All-around immune booster

Frankincense’s cancer-fighting benefits seem to come, in part, from its potent effects on the immune system. One study, conducted by researchers from Baylor University Medical Center, found that acts upon the expression of genes that help regulate the immune system, leading to cancer cell death. Another study, published in Phytotherapy Research, found that mice given frankincense exhibited increases in several key markers of immune function, primarily levels of white blood cells (lymphocytes) and anti-inflammatory activity.

Numerous studies have confirmed frankincense as a powerful anti-inflammatory. This, along with its other immune-boosting properties, may in part explain its usefulness in fighting infection and in treating autoimmune conditions such as asthma, rheumatoid arthritis and inflammatory bowel disease (IBD).

Frankincense can also be used to heal skin, including from acne and scarring, and can reduce anxiety levels.

If you wish to incorporate frankincense as a regular natural hBealth booster, it can be taken as an undiluted essential oil on the skin or as a few drops under the tongue. It can also be diffused and breathed in for respiratory conditions. Frankincense can also be purchased and consumed in powdered capsule form.

There are numerous species of frankincense, including Boswellia carteri, B. serrata and B. sacra. All three of these species have shown powerful anti-cancer effects in scientific tests.

B. carteri, native to east Africa, has been the species most heavily studied. B. sacra, also known as “sacred frankincense,” was until recently restricted to use by the Saudi royal household, and could only be purchased in Oman. Recently, however, a distillery opened up in Oman to produce essential oil of B. sacra for public sale.

Read More At: NaturalNews.com

Sources for this article include:
http://blogs.naturalnews.com
https://draxe.com/frankincense-oil-cancer/
http://www.naturalnews.com/025892_cancer_frankincense_oil.html

Dandelion Root Extract Found To Kill Leukemia Cells, Prostate Cancer Cells & Chemo-Resistant Melanoma

Dandelion root
Source: NaturalNews.com
Isabelle Z.
May 17, 2016

They might not be welcome in your yard, but it turns out that dandelions have tremendous potential when it comes to helping people who are suffering from cancer.

Chemo-resistant melanoma is now the most common type of cancer affecting Americans aged 25 to 29. The only option doctors can presently offer these patients is surgery to remove the tumor and its surroundings, followed by immunotherapy, which does not usually work when the melanoma has metastasized.

However, all that looks set to change, thanks to a humble plant that many people pull out of their gardens and throw away. At the University of Windsor in Ontario, the Department of Chemistry and Biochemistry has shown that dandelion root extract can cause human melanoma cells to essentially kill themselves without leading to any type of toxicity. In fact, their initial study saw cancer cells disintegrating within 48 hours, while healthy cells remained unaffected. The study was led by Professor Siyaram Pandey, PhD.

Concentrated dandelion root tea being used in clinical trials

These promising results prompted the non-profit organization Mitacs to reach out to AOR Inc., a Calgary company that produces natural health products, in order to develop a dandelion tea powder that is significantly stronger than that found in health food stores. They accomplish this by milling dandelion root, creating an extract from it, and then freeze-drying it into a powder that patients dissolve into hot water and then drink.

AOR is producing 6,000 doses of this tea for a clinical trial that will take place at the Windsor Regional Cancer Centre, and will involve 30 patients with various types of cancer, including leukemia, who have not had success with conventional therapy.

A statement on the website of the Dandelion Root Project at the University of Windsor says:

Since the commencement of this project, we have been able to successfully assess the effect of a simple water extract of dandelion root in various human cancer cell types, in the lab and we have observed its effectiveness against human T cell leukemia, chronic myelomonocytic leukemia, pancreatic and colon cancers, with no toxicity to non-cancer cells. Furthermore, these efficacy studies have been confirmed in animal models (mice) that have been transplanted with human colon cancer cells.

Researcher and medical oncologist Dr. Caroline Hamm said that some of her patients have noted improvements after drinking dandelion root tea from health food stores. The concentrated tea could prove to be even more effective, potentially saving countless lives.

Dandelion could help fight a number of cancers

A 2008 study published in the International Journal of Oncology showed that dandelion tea reduced breast and prostate cancer cells. A subsequent report in the same journal showed that a dietary supplement that contained dandelion suppressed the growth of prostate cancer cells. Dandelion extracts have also demonstrated their efficacy in treating breast cancer and leukemia in traditional Chinese medicine as well as in Native American medicine.

In addition, dandelion extracts show promise in fighting colon and pancreatic cancer cells.

Continue Reading At: NaturalNews.com

Huge: Monsanto Sues California to Keep Round Up Off Carcinogen List

roundup pesticides herbicide monsanto-735-273
Source: NaturalSociety.com
Christina Sarich
February 5, 2016

Months after the World Health Organization’s cancer research arm declared the herbicide chemical glyphosate ‘probably carcinogenic,’ the state of California announced a move to place a cancer label on products containing the ingredient. That would include biotech giant Monsanto’s best-selling herbicide, Round Up. Outraged about the new, Monsanto is now suing California to keep Round Up off the state’s list of carcinogens.

Monsanto recently reported that it filed the suit against the state’s Office of Environmental Health Hazard Assessment (OEHHA) and the agency’s acting director, Lauren Zeise, in California state court. This was the company’s response to OEHHA, who last September, issued plans to add glyphosate to the state’s list of chemicals known to cause cancer, making it the first state in the country to do so.

Monsanto has disputed OEHHA’s and the WHO’s International Agency for Research on Cancer’s (IARC) assessment, citing decades of studies finding “glyphosate to be safe”, including a 2007 study by OEHHA which concluded the chemical was unlikely to cause cancer.

We’ve learned a lot more about glyphosate since 2007, though. The Center for Food Safety has outlined instances of pancreatic, kidney, and other cancerous tumors linked to glyphosate exposure.

Still, Monsanto continues to say that its chemical concoction isn’t toxic. Many have seen the writings on the wall – that glyphosate and Round Up toxicity have been grossly underestimated.

Continue Reading At: NaturalSociety.com

Celery, Artichokes Contain Flavonoids That Kill Human Pancreatic Cancer Cells

Source: MedicalXPress.com

Celery, artichokes, and herbs, especially Mexican oregano, all contain apigenin and luteolin, flavonoids that kill human pancreatic cancer cells in the lab by inhibiting an important enzyme, according to two new University of Illinois studies.

“Apigenin alone induced in two aggressive human cell lines. But we received the best results when we pre-treated with apigenin for 24 hours, then applied the chemotherapeutic drug for 36 hours,” said Elvira de Mejia, a U of I professor of and food toxicology.

The trick seemed to be using the flavonoids as a pre-treatment instead of applying them and the chemotherapeutic drug simultaneously, said Jodee Johnson, a doctoral student in de Mejia’s lab who has since graduated.

“Even though the topic is still controversial, our study indicated that taking on the same day as chemotherapeutic drugs may negate the effect of those drugs,” she said.

“That happens because flavonoids can act as antioxidants. One of the ways that chemotherapeutic drugs kill cells is based on their pro-oxidant activity, meaning that flavonoids and may compete with each other when they’re introduced at the same time,” she explained.

Pancreatic cancer is a very , and there are few early symptoms, meaning that the disease is often not found before it has spread. Ultimately the goal is to develop a cure, but prolonging the lives of patients would be a significant development, Johnson added.

It is the fourth leading cause of cancer-related deaths, with a five-year survival rate of only 6 percent, she said.

Continue Reading At: MedicalExpress.com